JESSICA WOZAB: Open Payments
NPI 1093084295 · ROY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$545 in 31 payments from 15 companies in 2025. Trend: 2023 $511 · 2024 $882 · 2025 $545
Food & beverage: $545
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 5 | $86 |
| PFIZER INC. | 3 | $68 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $61 |
| Lilly USA, LLC | 3 | $44 |
| SANOFI-AVENTIS U.S. LLC | 2 | $43 |
| ABBVIE INC. | 2 | $41 |
| Astellas Pharma US Inc | 2 | $37 |
| Axsome Therapeutics, Inc. | 2 | $35 |
| Dynavax Technologies Corporation | 2 | $27 |
| Phathom Pharmaceuticals, Inc. | 2 | $25 |
Products named: TRELEGY ELLIPTA, NURTEC ODT, CAPLYTA, MOUNJARO, TZIELD, VRAYLAR, Veozah, Auvelity.
Industry payments across UT — which companies pay providers there.
